Status: Not yet recruiting
Safety and Efficacy of Baricitinib After Endovascular Treatment in Acute Anterior Circulation Large Vessel Occlusion: A Multicenter, Randomized Controlled Clinical Trial
The primary purpose of this study is to evaluate the efficacy and safety of Baricitinib combined with endovascular therapy in patients with acute anterior circulation large vessel occlusion, to address futile recanalization with priority, and to elucidating the mechanism of JAK/STAT pathway inhibition on neuroprotection and inflammatory regulation.
Participants needed: 750
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: The First Affiliated Hospital of University of Science and Technology of ChinaUpdated: Mar 4, 2026Locations: 1
Eligibility criteria
Age is 18 years old or above. [+5]
Intracranial hemorrhage confirmed by CT or MRI. [+10]